What's new in IDIS/Web:

 • New Drugs

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Continuing Education Articles

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

Notice: IDIS database discontinuation December 31, 2014.   Read more.

IDIS Logo   IDIS Monthly Update Information - January 2011

NEW DRUG TERM
ADENOVIRUS (CRAD)
C-31-G
COLLAGEN, MARINE PEPTIDES
CUPRIC CHLORIDE
DIHYDROCAPSIATE
EURYCOMA LONGIFOLIA
GSK-962040
IVACAFTOR
MBP-8599
MDX-1342
MILATUZUMAB
MITEMCINAL
MOG-3555
PIRAGLIATIN
PLINABULIN
PLP-139151
PRINABEREL
R-483
RO-5068760
SK-951
XMAB-5574

CODE
10120951
84220408
92000365
40120413
92000364
92510274
56160007
95000349
14000110
10120282
10120280
56160004
14000112
68200441
10120953
14000111
95000348
68200442
10120952
56160005
10120281


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
MB-22948 95000292ZAPRINAST 24120107


FDA APPROVAL PACKAGES

Article Numbers 648349-648362: Lurasidone Hydrochloride, Latuda. FDA Approval Package for NDA 200603. FDA Approval Package 2010.

Article Numbers 647615-647630: Dabigatran Etexilate Mesylate, Pradaxa. FDA Approval Package for NDA 22-512. FDA Approval Package 2010.

Article Numbers 647599-647614: Fingolimod, Gilenya. FDA Approval Package for NDA 22-527. FDA Approval Package 2010.

Article Numbers 647580-647598: Pegloticase, Krystexxa. FDA Approval Package for BLA 125293. FDA Approval Package 2010.


CONTINUING EDUCATION ARTICLES

Article Number 649028: Cada D J, Levien T L, Baker D E. Glycopyrrolate Oral Solution (0.15 CEU). Hosp Pharm 2010, 45:939-943.

Article Number 649021: De Luna K, Cada D J, Levien T L, Baker D E. Aztreonam Lysine Inhalation Solution (0.15 CEU). Hosp Pharm 2010, 45:634-638.

Article Number 649015: Cada D J, Levien T L, Baker D E. Liraglutide (0.15 CEU). Hosp Pharm 2010, 45:552-563.

Article Number 648573: Patel D, Macdougall C. How to Make Antimicrobial Stewardship Work: Practical Considerations for Hospitals of All Sizes (0.15 CEU) (IDIS Note: The 1.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 648571-648573). Hosp Pharm 2010, 45:S10-S18.

Article Number 648572: Horvat R T. Review of Antibiogram Preparation and Susceptibility Testing Systems (0.15 CEU) (IDIS Note: The 1.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 648571-648573). Hosp Pharm 2010, 45:S6-S9.

Article Number 648571: Cannella C. Importance and Impact of Antimicrobial Stewardship (0.15 CEU) (IDIS Note: The 1.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 648571-648573). Hosp Pharm 2010, 45:S1-S5.

Article Number 648570: Cada D J, Levien T L, Baker D E. Buprenorphine Transdermal System. Hosp Pharm 2010, 45:863-870.

Article Number 648540: Anonymous. Miconazole (Oravig) for Oropharyngeal Candidiasis (0.1 CEU) (IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 648538-648540). Med Lett Drugs Ther 2010, 52:95-96.

Article Number 648539: Anonymous. Aliskiren/Amlodipine (Tekamlo): Another Combination Tablet for Hypertension (0.1 CEU) (IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 648538-648540). Med Lett Drugs Ther 2010, 52:94-95.

Article Number 648538: Anonymous. Drugs for Kidney Stones (0.1 CEU) (IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 648538-648540). Med Lett Drugs Ther 2010, 52:93-94.

Article Number 648437: Wiglesworth A K, Ennis K M, Kockler D R. Belimumab: A Blys-Specific Inhibitor for Systemic Lupus Erythematosus (1.0 CEU). Ann Pharmacotherapy 2010, 44:1955-1961.

Article Number 648436: Segarra-Newnham M, Henneman A. Antibiotic Prophylaxis for Prevention of Spontaneous Bacterial Peritonitis in Patients Without Gastrointestinal Bleeding (1.0 CEU). Ann Pharmacotherapy 2010, 44:1946-1954.

Article Number 648435: Huang D, Cheng J W. Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (1.0 CEU). Ann Pharmacotherapy 2010, 44:1933-1945.


FDA ADVISORY COMMITTEE MEETINGS

Article Numbers 648473-648478: Arthritis Advisory Committee Meeting, November 16, 2010. FDA Advisory Committee 2010.

Article Numbers 648465-648472: Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, October 21-22, 2010. FDA Advisory Committee 2010.

Article Numbers 648460-648464: Vaccines and Related Biological Products Advisory Committee Meeting, May 7, 2010. FDA Advisory Committee 2010.

Article Numbers 647638-647643: Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, November 3, 2010. FDA Advisory Committee 2010.

Article Numbers 647632-647637: Psychopharmacologic Drugs Advisory Committee Meeting, September 16, 2010. FDA Advisory Committee 2010.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 648367: NICE Technology Appraisal Guidance #212: Bevacizumab in Combination with Oxaliplatin and Either Fluorouracil Plus Folinic Acid or Capecitabine for the Treatment of Metastatic Colorectal Cancer. NICE Technol Appraisal Guid 2010.

Article Number 648366: NICE Technology Appraisal Guidance #211: Prucalopride for the Treatment of Chronic Constipation in Women. NICE Technol Appraisal Guid 2010.

Article Number 648365: NICE Technology Appraisal Guidance #210: Clopidogrel and Modified-Release Dipyridamole for the Prevention of Occlusive Vascular Events. NICE Technol Appraisal Guid 2010.

Article Number 648364: NICE Technology Appraisal Guidance #209: Imatinib for the Treatment of Unresectable and/or Metastatic Gastrointestinal Stromal Tumours. NICE Technol Appraisal Guid 2010.

Article Number 648363: NICE Technology Appraisal Guidance #208: Trastuzumab for the Treatment of Her2-Positive Metastatic Gastric Cancer. NICE Technol Appraisal Guid 2010.


College of Pharmacy